In This Issue
The Journal of Thoracic Oncology in the Next Decade
FGFR Signaling as a Target for Lung Cancer Therapy
Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting
Minimally Invasive versus Open Thymectomy for Thymic Malignancies: Systematic Review and Meta-Analysis
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer
PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non–Small Cell Lung Cancer
Metabolite Profiles of the Serum of Patients with Non–Small Cell Carcinoma
Patients with Advanced Non–Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?
Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)
Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma
Lymph Node Dissection in Thymic Malignancies: Implication of the ITMIG Lymph Node Map, TNM Stage Classification, and Recommendations
Are Anthracycline-Based Regimens Truly Indicated To Be the Standard Chemotherapy Regimen for Thymic Carcinoma?
Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients
An Unusual Metastatic Site for Primary Lung Cancer: The Spleen
Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment
Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non–Small Cell Lung Cancer in the U.S. National Cancer Data Base
The Frequency of Rare EGFR Mutations Is Higher than that of Classical Ones
Differences in the Epidemiology of Rare EGFR Mutations in Different Populations